To Our Valued Customers
2021. Március 4.
We have exciting and very positive news to share with you! Today, we announced that our parent company Colfax Corporation (NYSE: CFX) intends to build on our strategic momentum by separating into two independent and publicly-traded companies—one business will focus on fabrication technologies (ESAB) and the other on specialty medical technologies (MedTech Co. and DJO).
From a leadership perspective, I will continue as CEO of ESAB with our current team. Together, we will continue to strengthen ESAB’s fabrication market leadership. ESAB expects to invest its significant free cash flow into growth-related capital investments, innovation, productivity and strategic acquisitions.
Please click here to read our press release announcing this news.
For our valued customers, nothing will change during the separation period, which is targeted to be completed in the first quarter of 2022, subject to various conditions as described in today’s announcement. Our focus on continuous improvement – with the highest quality, standards and ethics – will continue in everything we do. You can expect us to continue to launch exciting new products, as well as increase our capability in digital analytics, robotics and gas control.
Once separated, we believe we will be a stronger partner to you. As an independent, publicly-traded company focused on fabrication technology, we believe we are positioned to accelerate our momentum, unlock our full growth potential, and capitalize on distinct opportunities going forward.
Thank you for your support.
Shyam P. Kambeyanda